FOXM1: This transcription factor seems to be overexpressed in primary AML cells for most patients; decreased expression is associated with G2-arrest and reduced levels of Aurora kinase B, cyclin B1 and CDC25B together with increased levels of p21 and p27 at the protein level [136]. Here, CDC25B is linked to acute myeloid leukemia.